- Home
- SUZ vs NBIX Comparison
SUZ vs NBIX Comparison
Compare SUZ & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUZ
- NBIX
- Stock Information
- Founded
- SUZ 1924
- NBIX 1992
- Country
- SUZ Brazil
- NBIX United States
- Employees
- SUZ N/A
- NBIX N/A
- Industry
- SUZ Paper
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SUZ Basic Materials
- NBIX Health Care
- Exchange
- SUZ Nasdaq
- NBIX Nasdaq
- Market Cap
- SUZ 10.8B
- NBIX 14.4B
- IPO Year
- SUZ N/A
- NBIX 1996
- Fundamental
- Price
- SUZ $8.85
- NBIX $147.21
- Analyst Decision
- SUZ
- NBIX Strong Buy
- Analyst Count
- SUZ 0
- NBIX 18
- Target Price
- SUZ N/A
- NBIX $172.33
- AVG Volume (30 Days)
- SUZ 2.0M
- NBIX 1.1M
- Earning Date
- SUZ 11-06-2025
- NBIX 10-28-2025
- Dividend Yield
- SUZ 2.99%
- NBIX N/A
- EPS Growth
- SUZ 61.72
- NBIX 12.44
- EPS
- SUZ 0.99
- NBIX 4.19
- Revenue
- SUZ $9,603,137,110.00
- NBIX $2,682,700,000.00
- Revenue This Year
- SUZ $7.75
- NBIX $23.68
- Revenue Next Year
- SUZ $15.00
- NBIX $18.02
- P/E Ratio
- SUZ $8.82
- NBIX $35.13
- Revenue Growth
- SUZ 17.39
- NBIX 19.61
- 52 Week Low
- SUZ $8.41
- NBIX $84.23
- 52 Week High
- SUZ $10.98
- NBIX $157.67
- Technical
- Relative Strength Index (RSI)
- SUZ 40.82
- NBIX 54.30
- Support Level
- SUZ $8.73
- NBIX $133.62
- Resistance Level
- SUZ $9.25
- NBIX $157.67
- Average True Range (ATR)
- SUZ 0.14
- NBIX 5.20
- MACD
- SUZ -0.01
- NBIX 0.58
- Stochastic Oscillator
- SUZ 21.13
- NBIX 56.13
About SUZ Suzano S.A.
Suzano SA produces and sells pulp and a variety of paper products. The company organizes itself into two segments based on product type: Pulp and Paper. The Pulp segment generates the majority of revenue. The firm's product portfolio includes printing and writing paper, paperboard, diapers, and sanitary napkins. The company owns forest land and plants in Brazil, where it harvests timber and turns the timber into pulp and paper in its plants.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.